ProfileGDS4718 / 230020_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 20% 37% 51% 36% 49% 70% 64% 36% 38% 43% 50% 36% 48% 59% 63% 39% 55% 45% 52% 42% 32% 51% 42% 48% 44% 57% 50% 57% 41% 54% 47% 61% 35% 34% 54% 69% 56% 38% 42% 49% 39% 46% 52% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1647920
GSM549102patient 115, normal, homogenized [OPG study]4.8574837
GSM549104patient 119, normal, homogenized [OPG study]5.5773251
GSM549108patient 138, normal, homogenized [OPG study]4.8383736
GSM549119patient 077, normal, homogenized [OPG study]5.4894549
GSM549133patient 032, cancer, homogenized [OPG study]6.9064770
GSM549139patient 042, cancer, homogenized [OPG study]6.4103564
GSM549099patient 107, normal, homogenized [OPG study]4.8127736
GSM549109patient 139, normal, homogenized [OPG study]4.9415538
GSM549110patient 046, normal, homogenized [OPG study]5.1401243
GSM549114patient 063, normal, homogenized [OPG study]5.4834950
GSM549122patient 082, normal, homogenized [OPG study]4.828836
GSM549134patient 033, cancer, homogenized [OPG study]5.387648
GSM549136patient 036, cancer, homogenized [OPG study]5.9919659
GSM549140patient 044, cancer, homogenized [OPG study]6.3604663
GSM549111patient 047, normal, homogenized [OPG study]4.9326239
GSM549113patient 057, normal, homogenized [OPG study]5.7421355
GSM549132patient 031, cancer, homogenized [OPG study]5.2571245
GSM549137patient 038, cancer, homogenized [OPG study]5.6197152
GSM549142patient 047, cancer, homogenized [OPG study]5.2392142
GSM549100patient 110, normal, homogenized [OPG study]4.62832
GSM549107patient 135, normal, homogenized [OPG study]5.5628851
GSM549115patient 068, normal, homogenized [OPG study]5.0316842
GSM549116patient 072, normal, homogenized [OPG study]5.3566348
GSM549120patient 078, normal, homogenized [OPG study]5.1690944
GSM549131patient 030, cancer, homogenized [OPG study]5.9223557
GSM549118patient 074, normal, homogenized [OPG study]5.5003650
GSM549129patient 027, cancer, homogenized [OPG study]5.9680157
GSM549123patient 088, normal, homogenized [OPG study]5.0054541
GSM549124patient 006, cancer, homogenized [OPG study]5.7608954
GSM549126patient 015, cancer, homogenized [OPG study]5.3486547
GSM549128patient 025, cancer, homogenized [OPG study]6.2547861
GSM549103patient 117, normal, homogenized [OPG study]4.8249135
GSM549117patient 073, normal, homogenized [OPG study]4.7004434
GSM549138patient 041, cancer, homogenized [OPG study]5.717254
GSM549141patient 045, cancer, homogenized [OPG study]6.860969
GSM549130patient 028, cancer, homogenized [OPG study]5.870256
GSM549101patient 111, normal, homogenized [OPG study]4.9191838
GSM549105patient 128, normal, homogenized [OPG study]5.1306942
GSM549106patient 134, normal, homogenized [OPG study]5.4113449
GSM549112patient 048, normal, homogenized [OPG study]4.9538139
GSM549125patient 011, cancer, homogenized [OPG study]5.3008946
GSM549127patient 024, cancer, homogenized [OPG study]5.6525452
GSM549135patient 035, cancer, homogenized [OPG study]5.0650542